PSORIASIS - McGraw-Hill Professional

110-8
SECTION 14 Dermatologic Disorders
Salicylic acid in bath oil:
• Apply the oil to the roots of your hairs (i.e., your scalp) every
night before sleeping. Cover with a shower cap overnight. The
next morning shampoo it off.
• Use the tar shampoo three times a week.
m CLINICAL COURSE: ALTERNATIVE THERAPY
Because of Mr Kent’s frustration with his increased psoriasis flareups
despite his prescription treatments, he is very interested in trying
anything to help decrease his symptoms. A friend who takes fish
oil for eczema told him it might help the psoriasis, so he asks about
the possibility of adding fish oil on a daily basis. For questions and
answers related to the use of fish oil/omega-3 fatty acids for the treatment
of psoriasis, please see Section 19 of this instructor’s guide.
REFERENCES
1. Law RMT. Psoriasis. In: Chisholm MA, Schwinghammer TL, Wells BG,
et al, eds. Pharmacotherapy Principles and Practice, 2nd ed. New York,
McGraw-Hill, 2010:1079–1091.
2. Schon MP, Boehncke WH. Psoriasis. N Engl J Med 2005;352:
1899–1912.
3. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the
management of psoriasis and psoriatic arthritis. Section 1. Overview
of psoriasis and guidelines of care for the treatment of psoriasis with
biologics. J Am Acad Dermatol 2008;58:826–850.
4. Papp KA, Gulliver W, Lynde CW, Poulin Y (Steering Committee).
Canadian Guidelines for the Management of Plaque Psoriasis, 1st
ed. June 2009. Endorsed by the Canadian Dermatology Association.
Available at: http://www.dermatology.ca/guidelines/cdnpsoriasisguidelines.
pdf. Accessed January 7, 2010.
5. Rahman P, Elder JT. Genetic epidemiology of psoriasis and psoriatic
arthritis. Ann Rheum Dis 2005;64(Suppl 2):ii37–ii39.
6. Smith N, Weymann A, Tausk FA, et al. Complementary and alternative
medicine for psoriasis: a qualitative review of the clinical trial literature.
J Am Acad Dermatol 2009;61:841–856.
7. Menter A, Korman NJ, Elmets CA, et al. 2009 guidelines of care for the
management of psoriasis and psoriatic arthritis—Section 3. Guidelines
of care for the management and treatment of psoriasis with topical
therapies. J Am Acad Dermatol 2009;60:643–659.
8. Menter A, Korman NJ, Elmets CA, et al. 2009 guidelines of care for the
management of psoriasis and psoriatic arthritis—Section 4. Guidelines
of care for the management and treatment of psoriasis with traditional
systemic agents. J Am Acad Dermatol 2009;61:451–485.
9. Menter A, Korman NJ, Elmets CA, et al. 2009 guidelines of care for the
management of psoriasis and psoriatic arthritis—Section 5. Guidelines
of care for the treatment of psoriasis with phototherapy and photochemotherapy.
J Am Acad Dermatol 2010;62:114–135.
10. Rosmarin DM, Lebwohl M, Elewski BE, et al. Cyclosporine and psoriasis:
2008 National Psoriasis Foundation Consensus Conference. J Am
Acad Dermatol 2010;62:838–853.
11. Kalb RE, Strober B, Weinstein G, Lebwohl M. Methotrexate and psoriasis:
2009 National Psoriasis Foundation Consensus Conference. J Am
Acad Dermatol 2009;60:824–837.
12. Leonardi CL, Kimball AB, Papp KA, et al. Efficacy and safety of ustekinumab,
a human interleukin-12/23 monoclonal antibody, in patients
with psoriasis: 76-week results from a randomised, double-blind,
placebo-controlled trial (PHOENIX 1). Lancet 2008;371:1665–1674.
13. Papp KA, Langley R, Lebwohl M, et al. Efficacy and safety of ustekinumab,
a human interleukin-12/23 monoclonal antibody, in patients
with psoriasis: 52-week results from a randomised, double-blind,
placebo-controlled trial (PHOENIX 2). Lancet 2008;371:1675–1684.
14. Poulin Y, Langley RD, Teixeira HD, et al. Biologics in the treatment
of psoriasis: clinical and economic overview. J Cutan Med Surg
2009:13(Suppl 2):S49–S57.
Copyright © 2011 by The McGraw-Hill Companies, Inc. All rights reserved.